News
Detailed price information for Sonnet Biotherapeutics Holdings Inc (SONN-Q) from The Globe and Mail including charting and trades.
Global spending on cloud infrastructure services reached $90.9 billion in the first quarter of 2025, according to estimates ...
Paul Bissonnette ignited debate by advocating for a $10 million annual contract for Sam Bennett, following his stellar ...
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN), currently valued at $3.67 million in market capitalization, announced that it has received a notice from The Nasdaq Stock Market LLC regarding ...
In graduate-level reasoning, measured by GPQA Diamond, OpenAI’s o3 (83.3%) and Google’s Gemini 2.5 Pro (83.0%) currently set the pace, though Claude Opus 4 (79.6%) and Sonnet 4 (75.4%) are ...
Anthropic said that Opus 4 “dramatically outperforms” previous models on memory capabilities, and it, and Sonnet 4, are 65% less likely than Sonnet 3.7 to use shortcuts or loopholes to ...
See Also: Shark Tank's Kevin O'Leary called Missing Ring his biggest mistake — Don't repeat history—invest in RYSE at just $1.90/share. A Growing Battlefield in AI-Driven Development ...
Marner is coming off the first 100-point season of his nine-year career with the Leafs with 27 goals and 75 assists in 81 games. It’s also the fourth time in his career that he has topped 90 ...
Sonnet’s Echo 13 Thunderbolt 5 SSD Dock is one of the best docks I’ve ever reviewed, with a premium SSD hidden inside. If you can afford it, this dock is very much worth the price.
PRINCETON, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing immunotherapeutic drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results